Answers are grounded in this paper and cite their sources.
Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, acquired clonal hemopoietic stem cell disorder characterized by complement mediated chronic intravascular haemolysis, bone marrow failure and life-threatening thrombosis. PNH results from a somatic mutation in the PIG-A gene on the X chromosome leading to deficiency of glycosylphosphatidylinositol (GPI) anchored complement regulatory protein predominantly CD55 & CD 59. The absence of CD55 & CD59 causes unregulated complement activation & ultimately formation of membrane attack complex (MAC) causes cell lysis. The discovery of complement inhibitors has dramatically improved survival and quality of life for patients with PNH. This review summarizes the pathophysiology, clinical manifestations, diagnostic approach, and evolving treatment strategies for PNH.
No takes yet. Share an insight, caveat, or question.
Muhammad Kamruzzaman (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: